|
Volumn 123, Issue 2, 2001, Pages 280-287
|
Monocyte-derived dendritic cells: A potential target for therapy in multiple sclerosis (MS)
|
Author keywords
Dendritic cells; Interferon beta; Methylprednisolone; Monocytes; Multiple sclerosis
|
Indexed keywords
BETA1 INTERFERON;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 4;
METHYLPREDNISOLONE;
ADULT;
ARTICLE;
AUTOIMMUNE DISEASE;
CELL DIFFERENTIATION;
CELL SELECTION;
CONTROLLED STUDY;
DENDRITIC CELL;
DRUG EFFECT;
FEMALE;
HUMAN;
HUMAN CELL;
IMMUNOLOGICAL TOLERANCE;
IMMUNOTHERAPY;
MALE;
MONOCYTE;
MULTIPLE SCLEROSIS;
PHENOTYPE;
PRIORITY JOURNAL;
ADULT;
CELL DIFFERENTIATION;
CYTOKINES;
DENDRITIC CELLS;
FEMALE;
HUMANS;
IMMUNOTHERAPY;
MALE;
MONOCYTES;
MULTIPLE SCLEROSIS;
|
EID: 0035111180
PISSN: 00099104
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2249.2001.01433.x Document Type: Article |
Times cited : (21)
|
References (45)
|